Works matching DE "RIBAVIRIN"

Results: 3348
    1
    2
    3
    4
    5

    Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany.

    Published in:
    2005
    By:
    • Siebert, Uwe;
    • Sroczynski, Gaby;
    • Wasem, Jürgen;
    • Greiner, Wolfgang;
    • Ravens-Sieberer, Ulrike;
    • Aidelsburger, Pamela;
    • Kurth, Bärbel;
    • Bullinger, Monika;
    • Schulenburg, J.-Matthias;
    • Wong, John;
    • Rossol, Siegbert;
    • Wasem, Jürgen;
    • Kurth, Bärbel M;
    • von der Schulenburg, J-Matthias Graf;
    • Wong, John B
    Publication type:
    journal article
    6

    Anti-infectives: Targeting SARS.

    Published in:
    Nature Reviews Microbiology, 2004, v. 2, n. 9, p. 686, doi. 10.1038/nrmicro985
    By:
    • Jones, Susan
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort.

    Published in:
    European Journal of Clinical Pharmacology, 2019, v. 75, n. 11, p. 1555, doi. 10.1007/s00228-019-02725-x
    By:
    • Barrail-Tran, Aurélie;
    • Goldwirt, Lauriane;
    • Gelé, Thibaut;
    • Laforest, Claire;
    • Lavenu, Audrey;
    • Danjou, Hélène;
    • Radenne, Sylvie;
    • Leroy, Vincent;
    • Houssel-Debry, Pauline;
    • Duvoux, Christophe;
    • Kamar, Nassim;
    • De Ledinghen, Victor;
    • Canva, Valérie;
    • Conti, Filomena;
    • Durand, François;
    • D'Alteroche, Louis;
    • Botta-Fridlund, Danielle;
    • Moreno, Christophe;
    • Cagnot, Carole;
    • Samuel, Didier
    Publication type:
    Article
    13

    Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials

    Published in:
    European Journal of Clinical Pharmacology, 2019, v. 75, n. 2, p. 207, doi. 10.1007/s00228-018-2566-6
    By:
    • Shuster, Diana L.;
    • Menon, Rajeev M.;
    • Ding, Bifeng;
    • Khatri, Amit;
    • Li, Hong;
    • Cohen, Eric;
    • Jewett, Melissa;
    • Cohen, Daniel E.;
    • Zha, Jiuhong
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study.

    Published in:
    Journal of Clinical Medicine, 2018, v. 7, n. 12, p. 473, doi. 10.3390/jcm7120473
    By:
    • Jiménez-Sousa, María Ángeles;
    • Gómez-Moreno, Ana Zaida;
    • Pineda-Tenor, Daniel;
    • Brochado-Kith, Oscar;
    • Sánchez-Ruano, Juan José;
    • Artaza-Varasa, Tomas;
    • Gómez-Sanz, Alicia;
    • Fernández-Rodríguez, Amanda;
    • Resino, Salvador
    Publication type:
    Article
    35

    Micro-elimination of hepatitis C in patients with chronic kidney disease: an Egyptian single-center study.

    Published in:
    Egyptian Journal of Internal Medicine, 2022, v. 34, n. 1, p. 1, doi. 10.1186/s43162-022-00139-3
    By:
    • George Michael, Tari;
    • Anwar, Christina A.;
    • Ahmed, Ossama A.;
    • Sarhan, Iman;
    • Elshazly, Yehia;
    • Shaker, Mohammed K.;
    • Eltabbakh, Mohammed;
    • Hashem, Walaa;
    • Tawfic, Safaa R.;
    • Kamel, Shimaa Y.;
    • Kandil, Doaa M.;
    • Naguib, Gina G.;
    • Khedr, Abdelrahman;
    • Ghanem, Eman A.;
    • Dabbous, Hany;
    • Doss, Wahid;
    • El-Sayed, Manal H.
    Publication type:
    Article
    36

    Evaluation of important human CYP450 isoforms and P‐glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail.

    Published in:
    Basic & Clinical Pharmacology & Toxicology, 2023, v. 132, n. 6, p. 487, doi. 10.1111/bcpt.13840
    By:
    • Neyshaburinezhad, Navid;
    • Shirzad, Nooshin;
    • Rouini, Mohammadreza;
    • Namazi, Soha;
    • Khoshayand, Mohammadreza;
    • Esteghamati, Alireza;
    • Nakhjavani, Manouchehr;
    • Ghasim, Hengameh;
    • Gloor, Yvonne;
    • Daali, Youssef;
    • Ardakani, Yalda H.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Efficacy of ribavirin against malignant glioma cell lines.

    Published in:
    Oncology Letters, 2014, v. 8, n. 6, p. 2469, doi. 10.3892/ol.2014.2569
    By:
    • AKIYOSHI OGINO;
    • EMIKO SANO;
    • YUSHI OCHIAI;
    • SHUN YAMAMURO;
    • SHINYA TASHIRO;
    • KAZUNARI YACHI;
    • TAKASHI OHTA;
    • TAKAO FUKUSHIMA;
    • YUTAKA OKAMOTO;
    • KOUHEI TSUMOTO;
    • TAKUYA UEDA;
    • ATSUO YOSHINO;
    • YOICHI KATAYAMA
    Publication type:
    Article
    48
    49
    50